White paper - Megatrends in global health impacting the Australian pharmaceutical industry
Abstract
Learn how tech advances, patient needs, regulations & economics are reshaping Australia's healthcare sector.
Summary
Australia’s healthcare system is undergoing rapid transformation – from advances in genomics to AI-powered diagnostics. In this comprehensive white paper, the French-Australian Chamber of Commerce & Industry (FACCI), with the support of the Embassy of France’s Regional Economic Department, explores the global megatrends reshaping the pharmaceutical industry and their specific impact on Australia.
This publication brings together insights from FACCI’s Health & Life Sciences Roundtable, held in February 2025 at MinterEllison Sydney, featuring stakeholders from across the pharmaceutical, biotech, and MedTech sectors. Former Health Minister Greg Hunt and other leading experts contributed to an in-depth discussion on the opportunities and policy challenges facing the industry today.
What's inside this white paper:
– The evolution of precision medicine, regenerative therapies and genomics-driven treatment
– How AI, telehealth, and predictive analytics are revolutionising care delivery
– Barriers to drug innovation: from regulatory bottlenecks to data-sharing limitations
– Strategic recommendations for modernising the Pharmaceutical Benefits Scheme (PBS)
– Cross-sector collaboration opportunities between French and Australian stakeholders
This white paper is essential reading for pharmaceutical executives, policy-makers, healthtech entrepreneurs, and investors who want to stay ahead of the curve in Australia’s evolving life sciences sector.